conference presentation of your reseach
TRANSCRIPT
![Page 1: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/1.jpg)
Speaker’s name: Dr Ramachandra Barik, Assistant professor Department of cardiology Nizam’s Institute of Medical science. Hyderabad INDIA.
I do not have any potential conflict of interest
![Page 2: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/2.jpg)
Device Closure Of Ventricular Septal Defect after 3 Weeks of Coronary Angioplasty.
![Page 3: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/3.jpg)
HAPPY NEW YEAR 2012
Dr Barik.
![Page 4: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/4.jpg)
CLINICAL HISTORY
60 YR/M, SMOKER, NON-DM, NON-HTN AWMI +STK+ ON 1.8.2011 WITHIN WINDOW
PERIOD OF 4 HRS AT A DISTRICT HOSPITAL SOB AT REST ON DAY 3-(3.8.2011)- PSM ECG –AWMI 2D ECHO- VSD ; MODERATE LV DYSFUNCTION REFERRED TO OUR HOSPITAL FOR FURTHER
MANAGEMENT
![Page 5: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/5.jpg)
ON EXAMINATION-
KILLIP II & ANGINA AT REST
BP: 100/70 MMHG, PULSE :109/MIN, RR: 22/MIN, AFEBRILE
JVP: NORMAL, LV – S3+, PSM IV/VI
ROOM AIR ARTERIAL SAT. 95%
OTHER SYSTEMS : B/L BASILLIAR CREPTS
![Page 6: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/6.jpg)
12 LEAD ECG12 LEAD ECG: TACHYCARDIA; Q – V1-V4
![Page 7: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/7.jpg)
RWMA + ( LAD TERRITORY HYPOKINETIC), ANTERO-APICAL VSD OF SIZE 10 mm, LVEF-35%, DIASTOLIC DYSFUNCTION +, NO PE, NO CLOT.
2D/3D-ECHO -04.08.2011
![Page 8: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/8.jpg)
2D ECHO –APICAL 4C
VSD -1.8CM FROM APEX TOWARDS BASE
![Page 9: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/9.jpg)
COLOUR DOPPLER – 4C :VSD
![Page 10: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/10.jpg)
COLOUR COMPARISION
![Page 11: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/11.jpg)
COLOUR COMPARISION
![Page 12: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/12.jpg)
CAG + CATH (4.8.2011): Hb-14gm%, with BMI- 22.03kg/m2; O2 CONS-200/MT
SVC - 50 %IVC - 76%
MVO2 - 56.5%RA - 62%
RV - 83%PA - 80%FA - 92%
RA – 2 MM HGRV – 20/0-4PA – 20/12 ,15PCWP - 17LV -100/0-8FA – 100/70
Qp/Qs - 1.86:1
![Page 13: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/13.jpg)
LAD -LESION
![Page 14: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/14.jpg)
RCA NORMAL
![Page 15: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/15.jpg)
LV ANGIO-SINGLE MUSCULAR VSD
![Page 16: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/16.jpg)
PLAN:Follow Guidelines?
PTCA TO LAD ? PTCA+VSD CLOSURE ? STAGED PROCEDURE ? SURGERY ?
![Page 17: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/17.jpg)
PTCA TO LADENDEAVOR RESOLUTE 3X15 MM
![Page 18: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/18.jpg)
SHARE YOUR IDEAS
PLEASE-IDEAL VSD
CLOSING TIME
![Page 19: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/19.jpg)
Amplatzer VSD Occluder-FAD APPROVED Cardi-O-Fix from Starway
Medical Technology,Inc.
DEVICE OPTION
![Page 20: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/20.jpg)
DELIVERY SYSTEM
![Page 21: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/21.jpg)
![Page 22: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/22.jpg)
Cardi-O-Fix 10mm device through 9 Fr sheath
![Page 23: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/23.jpg)
![Page 24: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/24.jpg)
ARTERIO-VENOUS LOOP
TERUMO- J -TIPPED- 0.35” X 260 CM
![Page 25: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/25.jpg)
SNARING IN PA
AMPLATZER GOOSE-NECK 10MM SNARE;MICROVENA CORPO.
![Page 26: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/26.jpg)
DELIVERY SHEATH ACROSS VSD
12 Fr x1800 CURVE STARWAY MEDICAL TECH.
![Page 27: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/27.jpg)
VSD OCCLUDER
CARDIO-O-FIX14 M.[STARWAY MEDICAL].
![Page 28: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/28.jpg)
AFTER RELEASE
![Page 29: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/29.jpg)
ECHO AFTER 3MONTHS
![Page 30: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/30.jpg)
REVIEW OF LITERATURE
![Page 31: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/31.jpg)
1. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32.2. Labrousse L, Choukroun E, Chevalier JM, Madonna F, Robertie F, Merlico F, et al. Surgery for post infarction ventricular septal defect (VSD): risk factors for hospital death and long term results. Eur J Cardiothorac Surg 2002;21:725-31.3. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med 2007;8:39-45.4. Ahmed J, Ruygrok PN, Wilson NJ, Webster MW, Greaves S, Gerber I. Percutaneous closure of post-myocardial infarction ventricular septal defects: a single centre experience. Heart Lung Circ 2008;17:119-23.5. Martinez MW, Mookadam F, Sun Y, Hagler DJ. Transcatheter closure of ischemic and post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv 2007; 69:403-7.
![Page 32: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/32.jpg)
6. Goldstein JA, Casserly IP, Balzer DT, Lee R, Lasala JM. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series. Catheter Cardiovasc Interv 2003;59:238-43.7. Caputo M, Wilde P, Angelini GD. Management of postinfarction ventricular septal defect. Br J Hosp Med 1995;54:562-6.8. Hachida M, Nakano H, Hirai M, Shi CY. Percutaneous transaortic closure of postinfarctional ventricular septal rupture. Ann Thorac Surg 1991;51:655-7.9. Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009; 30:81-8.10. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder. Heart 1998; 80:522-4.
![Page 33: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/33.jpg)
CASE REPORT
A 61-year-old male, hypertensive and diabetic for the past 20 years, was brought to
coronary care unit in CCF. He had sustained an anterior wall MI the previous day and was
thrombolyzed with streptokinase. On admission, pulse rate was 110/min and BP was
130/90 mm Hg. Auscultation revealed ……………….. Ajit S. Mullasari,*
MD,et.al.MMM,Chenai.
Catheterization and Cardiovascular Interventions 54:484–487 (2001)
![Page 34: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/34.jpg)
Between Sep.2003 and Feb. 2008, 29 consecutive patients underwent primary transcatheter VSD closure. Clinical, procedural, and outcome data were collected. Patients were divided into those with and those without cardiogenic shock at presentation for risk stratification. The median follow-up time of surviving patients was 730 days. The median time between VSD occurrence and closure was 1 day [interquartile range (IQR) 1–3] the initial procedural success rate was 86%. The shunt (Qp:Qs) could be reduced from 3.3 (IQR 2.3–3.8) to 1.4 (IQR 1.2–1.7; P , 0.001) Procedure-related complications such as major residual shunting, LV rupture, and device embolization occurred in 41%. The overall 30-day survival rate was 35%. Mortality was higher for cardiogenic shock in comparison to non-shock patients (88 vs. 38%, P , 0.001).Holger Thiele1*,et.al
![Page 35: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/35.jpg)
![Page 36: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/36.jpg)
TAKE HOME MESSAGE
USE OF CARDIO-O-FIX DEVICE INITIAL PTCAGAP OF 3 WEEKSVSD CLOSURE AVOIDANCE OF GA,TEE,BALLOON SIZING. NOT USED ANY STIFF GUIDE WIRE
MAKE THE PROCEDURE AS SIMPLE AS POSSIBLE WITH LEAST EXPENDITURE
![Page 37: conference presentation of your reseach](https://reader030.vdocuments.mx/reader030/viewer/2022032620/55c6c91cbb61ebbc6e8b484a/html5/thumbnails/37.jpg)
THANK U GIVING ME THIS OPPORTUNITY TO TO SHARE.